Samira Mubareka
#133,980
Most Influential Person Now
Clinical scientist
Samira Mubareka's AcademicInfluence.com Rankings
Samira Mubarekabiology Degrees
Biology
#14171
World Rank
#17858
Historical Rank
Virology
#373
World Rank
#381
Historical Rank
Immunology
#1004
World Rank
#1028
Historical Rank
Download Badge
Biology
Why Is Samira Mubareka Influential?
(Suggest an Edit or Addition)According to Wikipedia, Samira Mubareka is a Canadian microbiologist who is a clinical scientist at the Sunnybrook Health Sciences Centre in Toronto, Ontario. Her research considers the influenza virus, viral transmission and aerobiology. During the COVID-19 pandemic Mubareka isolated the genome of Severe acute respiratory syndrome coronavirus 2 in an effort to improve detection and diagnostics. She served as a member of the Ontario COVID-19 Science Advisory Table.
Samira Mubareka's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Influenza Virus Transmission Is Dependent on Relative Humidity and Temperature (2007) (1405)
- Diagnosing COVID-19: The Disease and Tools for Detection (2020) (1237)
- Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patients (2020) (580)
- Transmission of Influenza Virus in a Mammalian Host Is Increased by PB2 Amino Acids 627K or 627E/701N (2009) (546)
- The guinea pig as a transmission model for human influenza viruses. (2006) (332)
- High Temperature (30°C) Blocks Aerosol but Not Contact Transmission of Influenza Virus (2008) (293)
- Transmission of Influenza Virus via Aerosols and Fomites in the Guinea Pig Model (2009) (207)
- Audit and Feedback to Reduce Broad-Spectrum Antibiotic Use among Intensive Care Unit Patients A Controlled Interrupted Time Series Analysis (2012) (184)
- Sensitivity of Nasopharyngeal Swabs and Saliva for the Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (2020) (183)
- A simple protein-based surrogate neutralization assay for SARS-CoV-2 (2020) (147)
- Transmission of Pandemic H1N1 Influenza Virus and Impact of Prior Exposure to Seasonal Strains or Interferon Treatment (2009) (135)
- High-flow nasal cannula for acute hypoxemic respiratory failure in patients with COVID-19: systematic reviews of effectiveness and its risks of aerosolization, dispersion, and infection transmission (2020) (132)
- Immunomodulatory therapy for severe influenza (2011) (114)
- Detection of SARS-CoV-2 Viral Particles Using Direct, Reagent-Free Electrochemical Sensing (2020) (108)
- An analysis of COVID-19 vaccine sentiments and opinions on Twitter (2021) (103)
- Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis (2005) (101)
- Isolation, Sequence, Infectivity, and Replication Kinetics of Severe Acute Respiratory Syndrome Coronavirus 2 (2020) (95)
- Blocking Interhost Transmission of Influenza Virus by Vaccination in the Guinea Pig Model (2009) (89)
- Diagnosis and Management of First Case of COVID-19 in Canada: Lessons applied from SARS (2020) (87)
- Systemic and mucosal IgA responses are variably induced in response to SARS-CoV-2 mRNA vaccination and are associated with protection against subsequent infection (2022) (76)
- Real-time PCR-based SARS-CoV-2 detection in Canadian laboratories (2020) (70)
- Effects of Absolute Humidity, Relative Humidity, Temperature, and Wind Speed on Influenza Activity in Toronto, Ontario, Canada (2019) (66)
- Invasive Haemophilus influenzae in Manitoba, Canada, in the Postvaccination Era (2006) (63)
- A Comparison of Whole Genome Sequencing of SARS-CoV-2 Using Amplicon-Based Sequencing, Random Hexamers, and Bait Capture (2020) (61)
- Highly divergent white-tailed deer SARS-CoV-2 with potential deer-to-human transmission (2022) (54)
- A virtual care program for outpatients diagnosed with COVID-19: a feasibility study. (2020) (51)
- Mesenchymal Stromal (Stem) Cell Therapy Fails to Improve Outcomes in Experimental Severe Influenza (2013) (50)
- Hospital-wide rollout of antimicrobial stewardship: a stepped-wedge randomized trial. (2014) (45)
- Patients, Here Comes More Nanotechnology. (2016) (44)
- Holder pasteurization of donated human milk is effective in inactivating SARS-CoV-2 (2020) (40)
- The lung microvascular endothelium as a therapeutic target in severe influenza. (2013) (39)
- Evidence for sustained mucosal and systemic antibody responses to SARS-CoV-2 antigens in COVID-19 patients (2020) (38)
- The Pollution Particulate Concentrator (PoPCon): A platform to investigate the effects of particulate air pollutants on viral infectivity. (2018) (37)
- Experimental investigation of far‐field human cough airflows from healthy and influenza‐infected subjects (2020) (36)
- COVID-19 Hospitalizations, ICU Admissions and Deaths Associated with the New Variants of Concern (2021) (35)
- Identification of predictors of early infection in acute burn patients. (2013) (35)
- A scalable serology solution for profiling humoral immune responses to SARS‐CoV‐2 infection and vaccination (2022) (32)
- Multivalency transforms SARS-CoV-2 antibodies into ultrapotent neutralizers (2021) (30)
- A homogeneous split-luciferase assay for rapid and sensitive detection of anti-SARS CoV-2 antibodies (2020) (29)
- Severity of coronavirus respiratory tract infections in adults admitted to acute care in Toronto, Ontario (2020) (29)
- Rapid Identification of Bacteria Directly from Positive Blood Cultures by Use of a Serum Separator Tube, Smudge Plate Preparation, and Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry (2015) (29)
- Factors Associated with Choice and Success of One- Versus Two-Stage Revision Arthroplasty for Infected Hip and Knee Prostheses (2017) (28)
- Evaluation of Commercial Rubella Immunoglobulin G Avidity Assays (2006) (28)
- Experimental and natural evidence of SARS-CoV-2-infection-induced activation of type I interferon responses (2020) (27)
- Vibrio vulnificus Septicemia After Handling Tilapia Species Fish: A Canadian Case Report and Review. (2006) (26)
- Surveilling and Tracking COVID-19 Patients Using a Portable Quantum Dot Smartphone Device. (2021) (26)
- Low incidence of airborne SARS-CoV-2 in acute care hospital rooms with optimized ventilation (2020) (26)
- The opening and closing of empiric windows: the impact of rapid microbiologic diagnostics. (2014) (25)
- Diagnosing Antibiotic Resistance Using Nucleic Acid Enzymes and Gold Nanoparticles. (2021) (25)
- Divergent SARS-CoV-2 variant emerges in white-tailed deer with deer-to-human transmission (2022) (24)
- Candida dubliniensis bloodstream infection: a fatal case in a lung transplant recipient (2005) (24)
- Characterization of Experimental and Clinical Bioaerosol Generation During Potential Aerosol-Generating Procedures (2020) (24)
- Human Genes and Influenza (2008) (23)
- Positive no-touch surfaces and undetectable SARS-CoV-2 aerosols in long-term care facilities: An attempt to understand the contributing factors and the importance of timing in air sampling campaigns (2021) (23)
- Prediction of COVID-19 Waves Using Social Media and Google Search: A Case Study of the US and Canada (2021) (22)
- Use of an improved quantitative polymerase chain reaction assay to determine differences in human rhinovirus viral loads in different populations (2012) (22)
- Influenza-associated bacterial pneumonia; managing and controlling infection on two fronts (2015) (21)
- Famciclovir: a focus on efficacy and safety (2010) (21)
- Influenza Virus Infection in Guinea Pigs Raised as Livestock, Ecuador (2012) (20)
- Preclinical evaluation of a SARS-CoV-2 mRNA vaccine PTX-COVID19-B (2021) (19)
- Bioaerosols and Transmission, a Diverse and Growing Community of Practice (2019) (18)
- First detection of SARS-CoV-2 infection in Canadian wildlife identified in free-ranging white-tailed deer (Odocoileus virginianus) from southern Québec, Canada (2022) (18)
- Systematic Examination of Antigen-Specific Recall T Cell Responses to SARS-CoV-2 versus Influenza Virus Reveals a Distinct Inflammatory Profile. (2020) (18)
- Real-time PCR-based SARS-CoV-2 detection in Canadian laboratories. (2020) (17)
- BCG vaccination provides protection against IAV but not SARS-CoV-2 (2022) (17)
- Bioaerosol and surface sampling for the surveillance of influenza A virus in swine. (2019) (17)
- Influenza virus RNA recovered from droplets and droplet nuclei emitted by adults in an acute care setting (2019) (16)
- A mucosal antibody response is induced by intra-muscular SARS-CoV-2 mRNA vaccination (2021) (16)
- COVID-19 and threats to bats (2020) (16)
- Multivalency transforms SARS-CoV-2 antibodies into broad and ultrapotent neutralizers (2020) (16)
- Quantitative Assessment of Viral Dispersion Associated with Respiratory Support Devices in a Simulated Critical Care Environment (2021) (15)
- A "Made-in-Canada" serology solution for profiling humoral immune responses to SARS-CoV-2 infection and vaccination (2021) (14)
- Detection of Enterovirus D68 in Canadian Laboratories (2015) (14)
- Vasculature-on-a-chip platform with innate immunity enables identification of angiopoietin-1 derived peptide as a therapeutic for SARS-CoV-2 induced inflammation. (2022) (13)
- Sensitivity of midturbinate versus nasopharyngeal swabs for the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (2020) (13)
- Western Cold and Flu (WeCoF) aerosol study – preliminary results (2014) (13)
- Evaluating Humoral Immunity against SARS-CoV-2: Validation of a Plaque-Reduction Neutralization Test and a Multilaboratory Comparison of Conventional and Surrogate Neutralization Assays (2021) (13)
- Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in patients with COVID-19 (2021) (13)
- Rapid Identification of Candida Species from Positive Blood Cultures by Use of the FilmArray Blood Culture Identification Panel (2018) (12)
- Burden of noninfluenza respiratory viral infections in adults admitted to hospital: analysis of a multiyear Canadian surveillance cohort from 2 centres (2021) (12)
- Surface and air contamination with SARS-CoV-2 from hospitalized COVID-19 patients in Toronto, Canada (2021) (12)
- A simple protein-based SARS-CoV-2 surrogate neutralization assay (2020) (12)
- Evaluation of bioaerosol samplers for the detection and quantification of influenza virus from artificial aerosols and influenza virus–infected ferrets (2019) (12)
- Predicting the recombination potential of severe acute respiratory syndrome coronavirus 2 and Middle East respiratory syndrome coronavirus (2020) (12)
- Host parameters and mode of infection influence outcome in SARS-CoV-2-infected hamsters (2021) (11)
- Identification of a SARS-CoV-2 host metalloproteinase-dependent entry pathway differentially used by SARS-CoV-2 and variants of concern Alpha, Delta, and Omicron (2022) (10)
- Pulsed ultraviolet light decontamination of virus-laden airstreams (2017) (10)
- Intranasal HD-Ad vaccine protects the upper and lower respiratory tracts of hACE2 mice against SARS-CoV-2 (2021) (10)
- Longitudinal Assessment of SARS-CoV-2-Specific T Cell Cytokine-Producing Responses for 1 Year Reveals Persistence of Multicytokine Proliferative Responses, with Greater Immunity Associated with Disease Severity (2022) (9)
- Vapourized hydrogen peroxide decontamination in a hospital setting inactivates SARS-CoV-2 and HCoV-229E without compromising filtration efficiency of unexpired N95 respirators (2021) (9)
- Human coronaviruses disassemble processing bodies (2020) (9)
- A Colorimetric Test to Differentiate Patients Infected with Influenza from COVID‐19 (2021) (9)
- Surface and Air Contamination With Severe Acute Respiratory Syndrome Coronavirus 2 From Hospitalized Coronavirus Disease 2019 Patients in Toronto, Canada, March–May 2020 (2021) (9)
- Isolation, sequence, infectivity and replication kinetics of SARS-CoV-2 (2020) (9)
- Isolation, sequence, infectivity and replication kinetics of SARS-CoV-2 (2020) (9)
- Use of Diagnostic Tests for Presumed Lower Respiratory Tract Infection in Long‐Term Care Facilities (2007) (9)
- Influenza virus emitted by naturally-infected hosts in a healthcare setting (2015) (9)
- Persistence of T Cell and Antibody Responses to SARS-CoV-2 Up to 9 Months after Symptom Onset (2021) (8)
- Influenza Virus: The Biology of a Changing Virus (2010) (8)
- Co-circulation of multiple genotypes of human rhinovirus during a large outbreak of respiratory illness in a veterans’ long-term care home (2013) (8)
- The Diagnostic Accuracy of Subjective Dyspnea in Detecting Hypoxemia Among Outpatients with COVID-19 (2020) (8)
- Increased environmental sample area and recovery of Clostridium difficile spores from hospital surfaces by quantitative PCR and enrichment culture (2018) (8)
- Comparison of qPCR versus culture for the detection and quantification of Clostridium difficile environmental contamination (2018) (8)
- Immunogenicity of convalescent and vaccinated sera against clinical isolates of ancestral SARS-CoV-2, Beta, Delta, and Omicron variants (2022) (8)
- Experimental Measurements Of Far Field Cough Airflows Produced By Healthy And Influenza-Infected Subjects (2018) (8)
- An innovative mobile data collection technology for public health in a field setting (2018) (7)
- Diagnostic accuracy of subjective dyspnoea in detecting hypoxaemia among outpatients with COVID-19: a retrospective cohort study (2021) (7)
- Protecting Frontline Health Care Workers from COVID-19 with Hydroxychloroquine Pre-exposure Prophylaxis: A structured summary of a study protocol for a randomised placebo-controlled multisite trial in Toronto, Canada (2020) (7)
- Using Genetic Distance from Archived Samples for the Prediction of Antibiotic Resistance in Escherichia coli (2020) (7)
- The Thiazole-5-Carboxamide GPS491 Inhibits HIV-1, Adenovirus, and Coronavirus Replication by Altering RNA Processing/Accumulation (2021) (7)
- Differential Expression of Serum Exosome microRNAs and Cytokines in Influenza A and B Patients Collected in the 2016 and 2017 Influenza Seasons (2021) (6)
- Identification and differential usage of a host metalloproteinase entry pathway by SARS-CoV-2 Delta and Omicron (2022) (6)
- Routine Asymptomatic SARS-CoV-2 Screen Testing of Ontario Long-Term Care Staff After COVID-19 Vaccination (2021) (6)
- Genotyping SARS-CoV-2 through an interactive web application (2020) (6)
- Influenza Vaccine Effectiveness Against All-Cause Mortality Following Laboratory-Confirmed Influenza in Older Adults, 2010–2011 to 2015–2016 Seasons in Ontario, Canada (2020) (6)
- Risk of dispersion or aerosol generation and infection transmission with nasopharyngeal and oropharyngeal swabs for detection of COVID-19: a systematic review (2021) (6)
- Whole genome sequence of Corynebacterium kroppenstedtii isolated from a case of recurrent granulomatous mastitis (2020) (5)
- Acanthamoeba species Keratitis in a Soft Contact Lens Wearer Molecularly Linked to Well Water. (2006) (5)
- Temporal Dynamics and Evolution of SARS-CoV-2 Demonstrate the Necessity of Ongoing Viral Genome Sequencing in Ontario, Canada (2021) (4)
- Two DNA vaccines protect against severe disease and pathology due to SARS-CoV-2 in Syrian hamsters (2022) (4)
- Aerosol generation during pulmonary function testing: Monitoring during different testing modalities (2021) (3)
- Don’t misrepresent link between bats and SARS (2018) (3)
- Evaluation of mobile real-time polymerase chain reaction tests for the detection of severe acute respiratory syndrome coronavirus 2 (2021) (3)
- Early temporal dynamics of cellular responses to SARS-CoV-2 (2020) (3)
- Guidance on the use of antiviral agents for the 2019-2020 influenza season. (2020) (2)
- Capillary-Assisted Molecular Pendulum Bioanalysis. (2022) (2)
- An Unusual Cause of False-Positive Results with the BD GeneOhm Cdiff Assay (2013) (2)
- Viral dynamics of the SARS-CoV-2 Omicron Variant among household contacts with 2 or 3 COVID-19 vaccine doses (2022) (2)
- Similar duration of viral shedding of the severe acute respiratory coronavirus virus 2 (SARS-CoV-2) delta variant between vaccinated and incompletely vaccinated individuals (2022) (2)
- Persistent infection with severe acute respiratory coronavirus virus 2 (SARS-CoV-2) in a patient with untreated human immunodeficiency virus (HIV) (2022) (2)
- Use of antiviral drugs for seasonal influenza: Foundation document for practitioners-Update 2019. (2019) (2)
- Transmission of H9N2 Low Pathogenicity Avian Influenza Virus (LPAIV) in a Challenge-Transmission Model (2022) (2)
- Don't misrepresent link between bats and SARS. (2018) (2)
- Detection of Enterovirus D 68 in Canadian Laboratories (2015) (2)
- Medical air in healthcare institutions: A chemical and biological study (2019) (2)
- Determining the Protective Efficacy of Toll-Like Receptor Ligands to Minimize H9N2 Avian Influenza Virus Transmission in Chickens (2023) (1)
- Screening Large Population Health Databases for Potential Coronavirus Disease 2019 Therapeutics: A Pharmacopeia-Wide Association Study of Commonly Prescribed Medications (2022) (1)
- Sequence, infectivity and replication kinetics of SARS-CoV-2 isolated from COVID-19 patients in Canada (2020) (1)
- Persistent Infection with SARS-CoV-2 in a Person with Untreated HIV. (2022) (1)
- Systematic genome-scale identification of host factors for SARS-CoV-2 infection across models yields a core single gene dependency; ACE2 (2021) (1)
- Western Cold and Flu (WeCoF) aerosol study – preliminary results (2014) (1)
- Exposure route, sex, and age influence disease outcome in a golden Syrian hamster model of SARS-CoV-2 infection (2021) (1)
- Association between initial symptoms and subsequent hospitalization in outpatients with COVID-19: A cohort study. (2021) (1)
- 2020-2021 AMMI Canada guidance on the use of antiviral drugs for influenza in the setting of co-circulation of seasonal influenza and SARS-CoV-2 viruses in Canada. (2020) (1)
- Aerosol Spread and Communicability of Respiratory Viruses (2014) (1)
- 512. Healthcare-Acquired (HA) Carbapenemase-Producing Enterobacteriales (CPE) in Southern Ontario, Canada: To Whom Are We Transmitting CPE? (2019) (1)
- SARS-CoV-2 wildlife surveillance in Ontario and Québec, Canada (2021) (1)
- Similar Duration of Viral Shedding of the Delta Variant of SARS-CoV-2 Between Vaccinated and Incompletely Vaccinated Individuals. (2022) (1)
- GS-441524 Parent Nucleoside to Remdesivir Can Effectively Inhibits Sars-Cov-2 Omicron Infections in Human Lung Organoids (2023) (0)
- Antibody avidity and multi-specificity combined to confer protection against SARS-CoV-2 and resilience against viral escape (2022) (0)
- Treatment with Toll-like Receptor (TLR) Ligands 3 and 21 Prevents Fecal Contact Transmission of Low Pathogenic H9N2 Avian Influenza Virus (AIV) in Chickens (2023) (0)
- 501. Risk of Infection in Persons Colonized with Carbapenemase-Producing Enterobacteriales (CPE) in Ontario, Canada (2019) (0)
- 2021-2022 AMMI Canada guidance on the use of antiviral drugs for influenza in the COVID-19 pandemic setting in Canada. (2022) (0)
- Contributors (2006) (0)
- Expression of chemokines and cytokines in influenza A and B patients have a significant correlation to the levels of serum miRNAs (2020) (0)
- Decrease in Antibodies Against SARS-CoV-2 Over Time and Current Role of Serological Testing (2020) (0)
- Evaluating the impact of statin use on influenza vaccine effectiveness and influenza infection in older adults. (2023) (0)
- 89. On-going impact of the SARS-CoV-2 pandemic on the evolution of carbapenemase-producing Enterobacterales in Ontario, Canada (2022) (0)
- Strengthening a One Health approach to emerging zoonoses (2023) (0)
- Use of whole genome sequencing to identify low-frequency mutations in COVID-19 patients treated with remdesivir (2022) (0)
- Rollout Strategy for the Pfizer-BioNTech COVID-19 Vaccine in Ontario (2021) (0)
- SARS-COV-2: FROM SECRET LIFE TO GLOBAL PANDEMIC (2021) (0)
- Reply to: Viral Dispersion in the Intensive Care Unit: The Wind Effect. (2021) (0)
- Two DNA vaccines protect against severe disease and pathology due to SARS-CoV-2 in Syrian hamsters (2022) (0)
- Real-time PCR-based SARS-CoV-2 detection in Canadian laboratories. (2020) (0)
- Erratum for Lin et al., “Longitudinal Assessment of SARS-CoV-2-Specific T Cell Cytokine-Producing Responses for 1 Year Reveals Persistence of Multicytokine Proliferative Responses, with Greater Immunity Associated with Disease Severity” (2023) (0)
- Comparison of SARS-CoV-2 Viral Loads in the Nasal Mucosa of Patients Infected With BA.1, BA.2, or BA.5 Omicron Lineages (2022) (0)
- SARS-CoV-2 RBD and its Variants can Induce Platelet Activation and Clearance: Implications for Antibody Therapy and Vaccinations Against COVID-19 (2023) (0)
- A Quantitative Study of Particle Dispersion Due to Respiratory Support Modalities in Pre-Hospital and In-Hospital Critical Care Environments (2021) (0)
- Evaluation of Commercial Rubella IgG Avidity Assays (2006) (0)
- COVID-19 Genotyping Tool (CGT) - v0.2.2 (2020) (0)
- Management Challenges of Prosthetic Joint Infections at Sunnybrook Health Sciences Centre (2015) (0)
- Disseminated hypervirulent Klebsiella pneumoniae causing endophthalmitis, and lung and liver abscesses (2022) (0)
- A Quantitative Study of Particle Dispersion due to Respiratory Support Modalities in PC-12 Aircraft: Prehospital Patient Transport. (2021) (0)
- Nasal colonization with Streptococcus pneumoniae and Staphylococcus aureus among hospitalized patients with laboratory-confirmed influenza. (2018) (0)
- 411. Significance of a Known Epidemiological Link to a COVID-19 Index Case and Severity of COVID-19 Infection (2021) (0)
- The Potential Protective Role of GS-441524, a Metabolite of the Prodrug Remdesivir, in Vaccine Breakthrough SARS-CoV-2 Infections (2022) (0)
- Emergence of a mutation in the nucleocapsid gene of SARS-CoV-2 interferes with PCR detection in Canada (2022) (0)
- Reply to Tandjaoui-Lambiotte et al.: Viral Dispersion in the ICU: The Wind Effect (2021) (0)
- Host Expression Profiling from Diagnostic COVID-19 Swabs Associate Upper Respiratory Tract Immune Responses with Radiologic Lung Pathology and Clinical Severity (2023) (0)
- Natural Language Processing for Clinical Laboratory Data Repository Systems: Implementation and Evaluation for Respiratory Viruses (2022) (0)
- Publisher Correction: Divergent SARS-CoV-2 variant emerges in white-tailed deer with deer-to-human transmission (2022) (0)
- Survival-based CRISPR genetic screens across a panel of permissive cell lines identify common and cell-specific SARS-CoV-2 host factors (2022) (0)
- Validation of CXCL10 as a biomarker of respiratory tract infections detectable by lateral flow immunoassay (2022) (0)
- Monitoring Chemical Contamination of Medical Air Produced On-Site in a Healthcare Institution Using Low-Cost Air Quality Sensors (2018) (0)
- Transmission of Pandemic H1N1 Influenza Virus and Impact of Prior Exposure to Seasonal Strains or Interferon Treatment (cid:1) (2009) (0)
- Genotyping SARS-CoV-2 Variants Using Ratiometric Nucleic Acid Barcode Panels. (2023) (0)
- SARS-CoV-2 Surveillance in Peri-Domestic and Wildlife Species in Ontario, Canada (2022) (0)
- Assessing the utilization and impact of a newly established outpatient parenteral antimicrobial therapy (OPAT) program. (2020) (0)
- Using the Association Between Antibiotic Susceptibility and Genetic Relatedness to Rescue Old Drugs for Empiric Use (2019) (0)
- Immunity to SARS-CoV-2 persists 9 months post-symptoms with an altered T cell phenotype compared to influenza A virus-specific memory (2021) (0)
- Intranasal HD-Ad vaccine protects the upper and lower respiratory tracts of hACE2 mice against SARS-CoV-2 (2021) (0)
- Systematic examination of T cell responses to SARS-CoV-2 versus influenza virus reveals distinct inflammatory profile (2020) (0)
- Author Correction: Emergence of a mutation in the nucleocapsid gene of SARS-CoV-2 interferes with PCR detection in Canada (2022) (0)
- Data for: Medical Air in Healthcare Institutions: A Chemical and Biological Study (2019) (0)
- Chapter 37 – Pneumonia Secondary to Varicella and Measles (2006) (0)
- Natural Language Processing for Clinical Laboratory Repository Systems: Implementation and Evaluation for Respiratory Viruses (Preprint) (2022) (0)
- SARS-CoV-2 infection dysregulates the expression of clinically relevant drug metabolizing enzymes in Vero E6 cells and membrane transporters in human lung tissues (2023) (0)
- Recombination Potential of SARS-CoV-2 and MERS-CoV (2020) (0)
This paper list is powered by the following services:
Other Resources About Samira Mubareka
What Schools Are Affiliated With Samira Mubareka?
Samira Mubareka is affiliated with the following schools:
